MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$335M
1-Year Return
7.01%
This Quarter Return
-3.18%
1 Year Return
+7.01%
3 Year Return
+65.15%
5 Year Return
+135.64%
10 Year Return
+335.37%
AUM
$2.8B
AUM Growth
-$4.56B
(-62%)
Cap. Flow
-$4.16B
Cap. Flow
% of AUM
-148.28%
Top 10 Holdings %
Top 10 Hldgs %
26.34%
Holding
2,829
New
47
Increased
16
Reduced
2,170
Closed
587
Top Buys
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$15.8M |
| 2 |
Constellation Energy
CEG
|
+$1.13M |
| 3 |
Sea Limited
SE
|
+$1.05M |
| 4 |
AerCap
AER
|
+$347K |
| 5 |
Phillips Edison & Co
PECO
|
+$242K |
Top Sells
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$231M |
| 3 |
Amazon
AMZN
|
+$140M |
| 4 |
Tesla
TSLA
|
+$85.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$77.6M |
Sector Composition
| 1 | Technology | 22.41% |
| 2 | Healthcare | 12.39% |
| 3 | Financials | 12.03% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Lifecore Biomedical
LFCR
$291M
| $19.8K | ﹤0.01% |
1,714
-4,107
| -71% | -$47.6K |
|
2102
Janux Therapeutics
JANX
$1.51B
| $19.8K | ﹤0.01% |
1,382
-2,629
| -66% | -$37.7K |
|
2103
Personalis
PSNL
$541M
| $19.8K | ﹤0.01% |
2,418
-7,440
| -75% | -$60.9K |
|
2104
Citizens & Northern Corp
CZNC
$314M
| $19.8K | ﹤0.01% |
812
-3,532
| -81% | -$86.1K |
|
2105
Cogent Biosciences
COGT
$1.79B
| $19.8K | ﹤0.01% |
2,639
-8,012
| -75% | -$60K |
|
|
KBAL
2106
DELISTED
Kimball International
KBAL
| $19.7K | ﹤0.01% |
2,337
-7,108
| -75% | -$60.1K |
|
2107
Safe Bulkers
SB
$458M
| $19.5K | ﹤0.01% |
+4,096
| New | +$19.5K |
|
2108
Forestar Group
FOR
$1.45B
| $19.5K | ﹤0.01% |
1,097
-3,966
| -78% | -$70.4K |
|
2109
Sight Sciences
SGHT
$190M
| $19.5K | ﹤0.01% |
+1,683
| New | +$19.5K |
|
2110
Tiptree Inc
TIPT
$925M
| $19.4K | ﹤0.01% |
1,511
-1,421
| -48% | -$18.3K |
|
|
FXLV
2111
DELISTED
F45 Training Holdings Inc.
FXLV
| $19.4K | ﹤0.01% |
+1,811
| New | +$19.4K |
|
|
TBCH
2112
Turtle Beach Corporation Common Stock
TBCH
$300M
| $19.3K | ﹤0.01% |
907
-3,595
| -80% | -$76.5K |
|
|
EIGR
2113
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $19.3K | ﹤0.01% |
+78
| New | +$19.3K |
|
2114
South Plains Financial
SPFI
$651M
| $19.3K | ﹤0.01% |
725
-2,216
| -75% | -$58.9K |
|
2115
Regional Management Corp
RM
$421M
| $19.2K | ﹤0.01% |
396
-2,123
| -84% | -$103K |
|
|
CTT
2116
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $19.2K | ﹤0.01% |
2,344
-9,520
| -80% | -$78.1K |
|
2117
Cullinan Oncology
CGEM
$391M
| $19.2K | ﹤0.01% |
1,830
-5,590
| -75% | -$58.5K |
|
2118
Esperion Therapeutics
ESPR
$563M
| $19.1K | ﹤0.01% |
+4,114
| New | +$19.1K |
|
2119
Willdan Group
WLDN
$1.55B
| $19.1K | ﹤0.01% |
622
-2,586
| -81% | -$79.4K |
|
2120
Phathom Pharmaceuticals
PHAT
$856M
| $19.1K | ﹤0.01% |
1,402
-4,540
| -76% | -$61.8K |
|
|
CBAY
2121
DELISTED
Cymabay Therapeutics
CBAY
| $19.1K | ﹤0.01% |
+6,132
| New | +$19.1K |
|
2122
Intapp
INTA
$3.73B
| $19K | ﹤0.01% |
792
-2,420
| -75% | -$58.1K |
|
2123
Mersana Therapeutics
MRSN
$37.3M
| $19K | ﹤0.01% |
190
-191
| -50% | -$19.1K |
|
2124
Guaranty Bancshares
GNTY
$559M
| $19K | ﹤0.01% |
542
-1,657
| -75% | -$58K |
|
2125
VistaGen Therapeutics
VTGN
$107M
| $18.8K | ﹤0.01% |
506
-1,640
| -76% | -$61.1K |
|